Chair File: Leadership Rounds with Tom Priselac, CEO of Cedars-Sinai

Jan 25, 2021 - 01:25 PM by
Rod Hochman, M.D.
Dr. Hochman Leadership Rounds

This year, I look forward to continuing AHA’s Leadership Rounds, short conversations on trending topics with health care leaders from around the country.

Joining me to launch this year’s series is Tom Priselac, president and CEO of Cedars-Sinai in Los Angeles, and a former chair of the AHA Board of Trustees.

During this episode, we discuss the COVID-19 surges that California and many other states are experiencing. Tom shares his insights on expanding the administration of COVID-19 vaccines, including leveraging public-private partnerships. We also consider opportunities the pandemic has created to rethink health care delivery. 

I hope you find these talks interesting and useful. Look for them once a month as part of the chair file.

Rod Hochman, M.D.
AHA Chair

 

Related News Articles

Headline
AHA podcast: Physician leader shares lessons from women’s leadership program
In this AHA Physician Alliance podcast, Janine Adjo, M.D., chair and director of the pediatric residency program at SBH Health System Bronx, shares how she…
Headline
Biden continues national emergency declaration for COVID-19 pandemic
President Biden yesterday continued the national emergency for the COVID-19 pandemic beyond March 1. The renewed national emergency, along with the recently…
Headline
Senate urged to include provider relief funding in reconciliation package
The AHA and eight other hospital organizations today urged Senate leaders to include additional COVID-19 relief funding for health care providers in the…
Headline
FDA minority health videos explain COVID-19 vaccine safety
The Food and Drug Administration's Office of Minority Health and Health Equity today released two videos on COVID-19 vaccines and the importance of communities…
Headline
AHA receives CDC grants to promote COVID-19 vaccine confidence, prevent infection
The AHA has received $6 million in grants from the Centers for Disease Control and Prevention to promote clinician and public confidence in COVID-19 vaccines,…
Headline
FDA confirms safety, effectiveness of Johnson & Johnson COVID-19 vaccine candidate
Data submitted to the Food and Drug Administration confirms that Johnson & Johnson’s COVID-19 vaccine candidate is safe and effective. According to the…